Literature DB >> 7677803

Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix.

E Kristiansen1, A Jenkins, R Holm.   

Abstract

AIMS: To investigate the integration of human papillomavirus (HPV)16 in 13 HPV16 positive cervical squamous carcinomas.
METHODS: Samples were investigated by Southern blot analysis of the Pst I digestion pattern, two-dimensional gel-electrophoresis, and in situ hybridisation.
RESULTS: Integration of HPV16 was found in all cases. In 12 biopsy specimens episomal HPV16 DNA and integrated HPV16 DNA were seen. The episomal DNA occurred as dimers and multimers. In situ hybridisation showed that both integrated and episomal HPV16 DNA were present in the same cell in most tumour cell nuclei.
CONCLUSIONS: An intact episomal E2 gene is present in most cases of these cervical cancers, and could therefore replace the regulatory function of an integrated defective E2 gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7677803      PMCID: PMC501906          DOI: 10.1136/jcp.47.3.253

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames.

Authors:  K B Choo; C C Pan; S H Han
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

2.  Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix.

Authors:  M M Pater; A Pater
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

3.  Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa.

Authors:  M K el Awady; J B Kaplan; S J O'Brien; R D Burk
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

4.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.

Authors:  E Schwarz; U K Freese; L Gissmann; W Mayer; B Roggenbuck; A Stremlau; H zur Hausen
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

5.  Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.

Authors:  D Smotkin; F O Wettstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Variable-sized free episomes of Shope papilloma virus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some.

Authors:  F O Wettstein; J G Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

Authors:  C Yee; I Krishnan-Hewlett; C C Baker; R Schlegel; P M Howley
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

8.  The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours.

Authors:  M Dürst; A Kleinheinz; M Hotz; L Gissmann
Journal:  J Gen Virol       Date:  1985-07       Impact factor: 3.891

9.  Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA.

Authors:  L Pirisi; S Yasumoto; M Feller; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

10.  Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.

Authors:  T P Cripe; T H Haugen; J P Turk; F Tabatabai; P G Schmid; M Dürst; L Gissmann; A Roman; L P Turek
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  30 in total

1.  Human papilloma virus detection by in situ hybridisation signal amplification based on biotinylated tyramine deposition.

Authors:  K Cooper; L Taylor
Journal:  Mol Pathol       Date:  1997-08

Review 2.  Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

Authors:  K Cooper; J O McGee
Journal:  Mol Pathol       Date:  1997-02

Review 3.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

4.  Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix.

Authors:  L Pirami; V Giachè; A Becciolini
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

5.  Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.

Authors:  P P Ip; A Boerma; M Walczak; K Oosterhuis; J B Haanen; T N Schumacher; H W Nijman; T Daemen
Journal:  Gene Ther       Date:  2015-03-26       Impact factor: 5.250

6.  Detection of integrated human papillomavirus 16 DNA in squamous cell carcinoma of the cervix.

Authors:  K Cooper
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

Review 7.  Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

8.  Study of viral integration of HPV-16 in young patients with LSIL.

Authors:  G Gallo; M Bibbo; L Bagella; A Zamparelli; F Sanseverino; M R Giovagnoli; A Vecchione; A Giordano
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

9.  Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.

Authors:  B Kleter; L J van Doorn; J ter Schegget; L Schrauwen; K van Krimpen; M Burger; B ter Harmsel; W Quint
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma.

Authors:  Ruth Holm; Irene Kraus; Hanne Skomedal; Anita Langerød; Gunnar B Kristensen; Heidi Lyng
Journal:  Open Virol J       Date:  2008-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.